S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth

Patrick Casara; James Davidson; Audrey Claperon; Gaëtane Le Toumelin-Braizat; Meike Vogler; Alain Bruno; Maïa Chanrion; Gaëlle Lysiak-Auvity; Thierry Le Diguarher; Jérôme-Benoît Starck; Ijen Chen; Neil Whitehead; Christopher Graham; Natalia Matassova; Pawel Dokurno; Christopher Pedder; Youzhen Wang; Shumei Qiu; Anne-Marie Girard; Emilie Schneider; Fabienne Gravé; Aurélie Studeny; Ghislaine Guasconi; Franscesca Rocchetti; Sophie Maïga; Jean-Michel Henlin; Frédéric Colland; Laurence Kraus-Berthier; Steven Le Gouill; Martin JS Dyer; Roderick Hubbard; Mike Wood; Martine Amiot; Gerald M Cohen; John A. Hickman; Erick Morris; James Murray; Olivier Geneste

doi:10.18632/oncotarget.24744

S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth

Patrick Casara, James Davidson, Audrey Claperon, Gaëtane Le Toumelin-Braizat, Meike Vogler, Alain Bruno, Maïa Chanrion, Gaëlle Lysiak-Auvity, Thierry Le Diguarher, Jérôme-Benoît Starck, Ijen Chen, Neil Whitehead, Christopher Graham, Natalia Matassova, Pawel Dokurno, Christopher Pedder, Youzhen Wang, Shumei Qiu, Anne-Marie Girard, Emilie SchneiderFabienne Gravé, Aurélie Studeny, Ghislaine Guasconi, Franscesca Rocchetti, Sophie Maïga, Jean-Michel Henlin, Frédéric Colland, Laurence Kraus-Berthier, Steven Le Gouill, Martin JS Dyer, Roderick Hubbard, Mike Wood, Martine Amiot, Gerald M Cohen, John A. Hickman, Erick Morris, James Murray, Olivier Geneste

Chemistry

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	20075-20088
Number of pages	14
Journal	Oncotarget
Volume	9
Issue number	28
DOIs	https://doi.org/10.18632/oncotarget.24744
Publication status	Published - 13 Apr 2018

Bibliographical note

Access to Document

10.18632/oncotarget.24744Licence: CC BY

24744-345891-5-PB
© Casara et al.
Final published version, 4.69 MBLicence: CC BY

Cite this

Casara, P., Davidson, J., Claperon, A., Toumelin-Braizat, G. L., Vogler, M., Bruno, A., Chanrion, M., Lysiak-Auvity, G., Diguarher, T. L., Starck, J.-B., Chen, I., Whitehead, N., Graham, C., Matassova, N., Dokurno, P., Pedder, C., Wang, Y., Qiu, S., Girard, A.-M., ... Geneste, O. (2018). S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth. Oncotarget, 9(28), 20075-20088. https://doi.org/10.18632/oncotarget.24744

@article{4953532335204dfaa6a876bef5798e74,

title = "S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth",

author = "Patrick Casara and James Davidson and Audrey Claperon and Toumelin-Braizat, {Ga{\"e}tane Le} and Meike Vogler and Alain Bruno and Ma{\"i}a Chanrion and Ga{\"e}lle Lysiak-Auvity and Diguarher, {Thierry Le} and J{\'e}r{\^o}me-Beno{\^i}t Starck and Ijen Chen and Neil Whitehead and Christopher Graham and Natalia Matassova and Pawel Dokurno and Christopher Pedder and Youzhen Wang and Shumei Qiu and Anne-Marie Girard and Emilie Schneider and Fabienne Grav{\'e} and Aur{\'e}lie Studeny and Ghislaine Guasconi and Franscesca Rocchetti and Sophie Ma{\"i}ga and Jean-Michel Henlin and Fr{\'e}d{\'e}ric Colland and Laurence Kraus-Berthier and Gouill, {Steven Le} and Dyer, {Martin JS} and Roderick Hubbard and Mike Wood and Martine Amiot and Cohen, {Gerald M} and Hickman, {John A.} and Erick Morris and James Murray and Olivier Geneste",

note = "{\textcopyright} Casara et al.",

year = "2018",

month = apr,

day = "13",

doi = "10.18632/oncotarget.24744",

language = "English",

volume = "9",

pages = "20075--20088",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals",

number = "28",

}

Casara, P, Davidson, J, Claperon, A, Toumelin-Braizat, GL, Vogler, M, Bruno, A, Chanrion, M, Lysiak-Auvity, G, Diguarher, TL, Starck, J-B, Chen, I, Whitehead, N, Graham, C, Matassova, N, Dokurno, P, Pedder, C, Wang, Y, Qiu, S, Girard, A-M, Schneider, E, Gravé, F, Studeny, A, Guasconi, G, Rocchetti, F, Maïga, S, Henlin, J-M, Colland, F, Kraus-Berthier, L, Gouill, SL, Dyer, MJS, Hubbard, R, Wood, M, Amiot, M, Cohen, GM, Hickman, JA, Morris, E, Murray, J & Geneste, O 2018, 'S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth', Oncotarget, vol. 9, no. 28, pp. 20075-20088. https://doi.org/10.18632/oncotarget.24744

TY - JOUR

T1 - S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth

AU - Casara, Patrick

AU - Davidson, James

AU - Claperon, Audrey

AU - Toumelin-Braizat, Gaëtane Le

AU - Vogler, Meike

AU - Bruno, Alain

AU - Chanrion, Maïa

AU - Lysiak-Auvity, Gaëlle

AU - Diguarher, Thierry Le

AU - Starck, Jérôme-Benoît

AU - Chen, Ijen

AU - Whitehead, Neil

AU - Graham, Christopher

AU - Matassova, Natalia

AU - Dokurno, Pawel

AU - Pedder, Christopher

AU - Wang, Youzhen

AU - Qiu, Shumei

AU - Girard, Anne-Marie

AU - Schneider, Emilie

AU - Gravé, Fabienne

AU - Studeny, Aurélie

AU - Guasconi, Ghislaine

AU - Rocchetti, Franscesca

AU - Maïga, Sophie

AU - Henlin, Jean-Michel

AU - Colland, Frédéric

AU - Kraus-Berthier, Laurence

AU - Gouill, Steven Le

AU - Dyer, Martin JS

AU - Hubbard, Roderick

AU - Wood, Mike

AU - Amiot, Martine

AU - Cohen, Gerald M

AU - Hickman, John A.

AU - Morris, Erick

AU - Murray, James

AU - Geneste, Olivier

PY - 2018/4/13

Y1 - 2018/4/13

U2 - 10.18632/oncotarget.24744

DO - 10.18632/oncotarget.24744

M3 - Article

SN - 1949-2553

VL - 9

SP - 20075

EP - 20088

JO - Oncotarget

JF - Oncotarget

IS - 28

ER -